Dec 31, 2007:
iCo Therapeutics Inc. and Beanstalk Capital Ltd. Announce Completion of Arrangement
Oct 31, 2007:
Beanstalk Capital Ltd. and iCo Therapeutics Inc. amend arrangement agreement
Oct 16, 2007:
Beanstalk Capital Ltd. enters into arrangement agreement with iCo Therapeutics Inc.
Oct 9, 2007:
Isis Receives $1.25 Million Milestone Payment From iCo for Initiation of Phase 1 Study of iCo-007
Jan 22, 2007:
iCo Therapeutics Receives FDA Clearance to Initiate Clinical Trial in Diabetic Macular Edema
Jan 10, 2007:
iCo Therapeutics announces licensing deal
Jan 8, 2007:
Cambridge Antibody Tech. licenses monoclonal antibody for treatment of allergy disorders to iCo